专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20130252927A1 TREATING CONDITIONS ASSOCIATED WITH INCREASED EOTAXIN WITH 25-HYDROXYVITAMIN D3 审中-公开
标题翻译：与25羟基维生素D3相关的治疗条件
公开(公告)号：US20130252927A1
公开(公告)日：2013-09-26
申请号：US13990569
申请日：2011-12-05
申请人： Stephanie Krammer-Lukas , Elisabeth Stoecklin , Joseph Schwager , Swen Wolfram
发明人： Stephanie Krammer-Lukas , Elisabeth Stoecklin , Joseph Schwager , Swen Wolfram
IPC分类号： A61K31/593 , A23L1/303
CPC分类号： A61K31/593 , A23L33/155 , A23V2002/00 , A61K9/0053 , A61K9/48 , A61K2300/00
摘要： The present invention relates to treating/preventing conditions associated with an increased level of eotaxin in a human with 25-hydroxyvitamin D3 (calcifediol). Optionally, vitamin D3 may be used together with 25-hydroxyvitamin D3.
摘要翻译：本发明涉及治疗/预防与25-羟基维生素D3（calcifediol）在人中增加的嗜酸细胞活化趋化因子水平相关的病症。任选地，维生素D3可以与25-羟基维生素D3一起使用。

2. 发明申请

US20110300240A1 CAJANUS EXTRACTS AND GLUCOSAMINE FOR INFLAMMATORY DISORDERS 审中-公开
标题翻译： CAJANUS提取物和用于炎症性疾病的葡萄糖胺
公开(公告)号：US20110300240A1
公开(公告)日：2011-12-08
申请号：US13202154
申请日：2010-02-19
申请人： Daniel Raederstorff , Nathalie Richard , Joseph Schwager , Christof Wehrli , Swen Wolfram
发明人： Daniel Raederstorff , Nathalie Richard , Joseph Schwager , Christof Wehrli , Swen Wolfram
IPC分类号： A61K36/00 , A61P19/02 , A61Q19/00 , A61P25/00 , A61K8/97 , A61P29/00 , A61P3/10
CPC分类号： A61K31/7008 , A61K36/48 , A61K2300/00
摘要： The present invention relates to novel compositions comprising Cajanus and glucosamine as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.
摘要翻译：本发明涉及包含Cajanus和葡糖胺的新型组合物以及这些组合物作为药物，特别是作为治疗，共同治疗或预防炎症性疾病的药物的用途。

3. 发明申请

US20100056463A1 NOVEL COMPOSITIONS 有权
标题翻译：新组合
公开(公告)号：US20100056463A1
公开(公告)日：2010-03-04
申请号：US12373584
申请日：2007-07-12
申请人： Daniel Raederstorff , Nathalie Richard , Joseph Schwager , Karin Wertz
发明人： Daniel Raederstorff , Nathalie Richard , Joseph Schwager , Karin Wertz
IPC分类号： A61K31/7004 , A61K31/05
CPC分类号： A61K31/343 , A61K31/05 , A61K31/366 , A61K2300/00
摘要： The present invention relates to novel compositions comprising hydroxytyrosol and/or oleuropein (I) and at least one additional component e.g. selected from the group of ligustilide, oleuropein aglycone, magnolol, honokiol, genistein, resveratrol, EGCG, magnolia bark extract, cashew fruit extract and Glycyrrhiza foetida as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.
摘要翻译：本发明涉及包含羟基酪醇和/或橄榄苦蛋白（I）和至少一种另外的组分的新型组合物，选自ligustilide，橄榄苦苷苷，厚朴酚，和厚朴酚，染料木素，白藜芦醇，EGCG，木兰树皮提取物，腰果提取物和甘草，以及这些组合物作为药物的用途，特别是作为药物的用途治疗，共同治疗或预防炎症性疾病。

4. 发明申请

US20090298933A1 ORAL COMPOSITION CONTAINING EGCG AND LYCOPENE 审中-公开
标题翻译：含有EGCG和LYCOPENE的口服组合物
公开(公告)号：US20090298933A1
公开(公告)日：2009-12-03
申请号：US12520646
申请日：2007-12-13
申请人： Regina Goralczyk , Joseph Schwager , Karin Wertz
发明人： Regina Goralczyk , Joseph Schwager , Karin Wertz
IPC分类号： A61K31/352
CPC分类号： A61K8/31 , A61K8/498 , A61Q19/08
摘要： Composition containing the combination of (−)-epigallocatechin gallate (EGCG) and lycopene characterized in that the ratio of EGCG to lycopene is in the range of 100:1 to 1:1.
摘要翻译：包含（ - ） - 表没食子儿茶素没食子酸酯（EGCG）和番茄红素的组合的组合物，其特征在于EGCG与番茄红素的比例在100:1至1:1的范围内。

5. 发明授权

US07582674B2 Nutraceutical compositions and use thereof 有权
标题翻译：营养组合物及其用途
公开(公告)号：US07582674B2
公开(公告)日：2009-09-01
申请号：US10558042
申请日：2004-05-18
申请人： Daniel Raederstorff , Joseph Schwager , Volker Spitzer , Peter Weber
发明人： Daniel Raederstorff , Joseph Schwager , Volker Spitzer , Peter Weber
IPC分类号： A61K31/35 , A61K31/355 , A61K31/05
CPC分类号： A23G3/36 , A21D2/14 , A21D2/36 , A21D13/02 , A21D13/80 , A23C9/1315 , A23C9/1322 , A23G3/368 , A23G9/32 , A23G9/366 , A23L2/52 , A23L33/105 , A23L33/12 , A23L33/15 , A23V2002/00 , A61K31/202 , A61K31/353 , A61K31/355 , A61K2300/00 , A23V2250/1882 , A23V2250/187 , A23V2250/1868 , A23V2250/1874 , A23V2250/712 , A23V2250/714 , A23V2250/2116
摘要： Compositions including, as the active ingredients, resveratrol, a derivative, metabolite or analogue thereof, and at least one additional component selected from epigallocatechin gallate (EGCG), genestein, vitamin E, polyunsaturated fatty acids, gamma-linolenic acid and vitamin K are disclosed. Also disclosed, are methods of making such compositions including admixing resveratrol, a derivative, metabolite or analogue thereof, and at least one additional component selected from EGCG, genestein, vitamin E, polyunsaturated fatty acids, gamma-linolenic acid and vitamin K are disclosed. Methods for the treatment or prevention of inflammatory diseases including administering to a subject in need of such treatment resveratrol, a derivative, metabolite or analogue thereof, in combination with at least one additional component selected from epigallocatechin gallate (EGCG), genestein, vitamin E, polyunsaturated fatty acids, gamma-linolenic acid and vitamin K are also disclosed.
摘要翻译：公开了包含作为活性成分的白藜芦醇，衍生物，代谢物或类似物以及至少一种选自表没食子儿茶素没食子酸酯（EGCG），依那斯汀，维生素E，多不饱和脂肪酸，γ-亚麻酸和维生素K的另外组分的组合物。还公开了公开了制备这样的组合物的方法，包括混合白藜芦醇，衍生物，代谢物或其类似物，以及至少一种选自EGCG，genestein，维生素E，多不饱和脂肪酸，γ-亚麻酸和维生素K的其它组分。用于治疗或预防炎性疾病的方法，包括向需要这种治疗的受试者施用白藜芦醇，其衍生物，代谢物或类似物，与至少一种选自表没食子儿茶素没食子酸酯（EGCG），依达孕酮，维生素E，多不饱和脂肪酸，γ-亚麻酸和维生素K也被公开。

6. 发明申请

US20090186942A1 NOVEL NUTRACEUTICAL AND PHARMACEUTICAL COMPOSITIONS AND USE THEREOF FOR THE TREATMENT, CO-TREATMENT OR PREVENTION OF INFLAMMATORY DISORDERS 审中-公开
标题翻译：新型营养和药物组合物及其用于治疗，并发治疗或预防炎症性疾病的组合物
公开(公告)号：US20090186942A1
公开(公告)日：2009-07-23
申请号：US12279516
申请日：2007-02-13
申请人： Daniel Raederstorff , Joseph Schwager , Goede Schueler
发明人： Daniel Raederstorff , Joseph Schwager , Goede Schueler
IPC分类号： A61K31/192 , C07C65/03 , A61P29/00
CPC分类号： A61K31/05 , A61K31/60
摘要： The invention relates to novel compositions comprising a phenolic compound as well as to the use of these compositions as a medicament, in particular for the manufacture of a nutraceutical or pharmaceutical composition for the treatment, co-treatment or prevention of inflammatory disorders, such as arthritis, asthma, inflammatory bowel diseases, inflammatory diseases of the skin (e.g., psoriasis, eczema, atopic dermatitis, sunburn) and chronic inflammatory disorders, such as atherosclerosis, heart diseases, metabolic syndrome X, cancer, Alzheimer's disease and pre-stages thereof such as mild cognitive impairment. Also, the invention relates to the use of a cosmetic composition comprising a phenolic compound for the cosmetic treatment, co-treatment or prevention of inflammation of the skin, in particular for the cosmetic treatment, co-treatment or prevention of sunburn or of impure skin.
摘要翻译：本发明涉及包含酚类化合物的新型组合物以及这些组合物作为药物的用途，特别是用于制备用于治疗，共同治疗或预防炎症性疾病如关节炎的营养药物或药物组合物，哮喘，炎症性肠病，皮肤炎性疾病（例如牛皮癣，湿疹，特应性皮炎，晒伤）和慢性炎症性疾病如动脉粥样硬化，心脏病，代谢综合征X，癌症，阿尔茨海默氏病及其前期阶段作为轻度认知障碍。此外，本发明涉及包含酚类化合物的化妆品组合物在美容治疗，共同治疗或预防皮肤炎症中的用途，特别是用于美容治疗，共同治疗或预防晒伤或不纯的皮肤。

7. 发明申请

US20130005682A1 HYDROXYTYROSOL COMPOSITIONS FOR TREATMENT OF CARTILAGE INJURIES IN JOINTS 审中-公开
标题翻译：羟氯喹组合物治疗关节损伤的损伤
公开(公告)号：US20130005682A1
公开(公告)日：2013-01-03
申请号：US13616643
申请日：2012-09-14
申请人： Daniel RAEDERSTORFF , Joseph Schwager , Karin Wertz
发明人： Daniel RAEDERSTORFF , Joseph Schwager , Karin Wertz
IPC分类号： A61K31/05 , A61P19/04 , A61P19/02 , A61K31/737
CPC分类号： A61K31/05 , A61K31/202 , A61K31/7004 , A61K31/737 , A61K2300/00
摘要： The invention relates to the use of hydroxytyrosol for inducing or enhancing cartilage repair or cartilage regeneration. Furthermore, the invention relates to nutraceutical and pharmaceutical compositions comprising hydroxytyrosol for regeneration and repair of cartilage injuries in joints, in particular of traumatic cartilage injuries.
摘要翻译：本发明涉及羟基酪醇诱导或增强软骨修复或软骨再生的用途。此外，本发明涉及包含用于再生和修复关节软骨损伤的羟基酪醇，特别是创伤性软骨损伤的营养药物和药物组合物。

8. 发明申请

US20110014308A1 NOVEL COMPOSITIONS AND USE THEREOF FOR THE TREATMENT, CO-TREATMENT OR PREVENTION OF INFLAMMATORY DISORDERS. 审中-公开
标题翻译：新的组合物及其用于治疗，并发治疗或预防炎性疾病的组合物。
公开(公告)号：US20110014308A1
公开(公告)日：2011-01-20
申请号：US12747368
申请日：2008-12-11
申请人： Daniel Raederstorff , Nathalie Richard , Joseph Schwager , Karin Wertz
发明人： Daniel Raederstorff , Nathalie Richard , Joseph Schwager , Karin Wertz
IPC分类号： A61K36/63 , A61K31/726 , C07C39/11 , A61P29/00 , A61P19/02 , A61P17/00
CPC分类号： A61K31/726 , A61K31/05 , A61K31/737 , A61K36/63 , A61K2300/00
摘要： The present invention relates to novel compositions comprising hydroxytyrosol and chondroitin as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.
摘要翻译：本发明涉及包含羟基酪醇和软骨素的新型组合物以及这些组合物作为药物，特别是作为治疗，共同治疗或预防炎症性疾病的药物的用途。

9. 发明申请

US20090176873A1 NOVEL USE OF ORGANIC COMPOUNDS 审中-公开
标题翻译：有机化合物的新用途
公开(公告)号：US20090176873A1
公开(公告)日：2009-07-09
申请号：US11920346
申请日：2006-05-24
申请人： Ann Fowler , Daniel Raederstorff , Goede Schuler , Joseph Schwager
发明人： Ann Fowler , Daniel Raederstorff , Goede Schuler , Joseph Schwager
IPC分类号： A61K31/365 , C07D307/87 , A61P19/02
CPC分类号： A61K31/343
摘要： The present invention relates to the use of compounds of the formula (I) wherein the clotted line is an optional bond; R1 is butyl or butyryl if R2 is hydroxyl but is butyl if R2 is hydrogen; or R1 and R2 taken together are 1-butylidene optionally substituted by hydroxyl, methyl, or 3-(α,β-dimethylacrylyloxy)-pentylidenyl; X is a residue selected from the group consisting of X1, X2, X3, X4, and X5; wherein X is X2, X3 or X5 if the dotted line in formula (I) is absent; and X is X1, X4 or X5 if the dotted line signifies a bond in formula (I) above; R3 is hydroxyl or butyryl; and n is 1 or 2, as agents for the prevention, control and treatment of conditions requiring modulation of inflammation in mammals. In another aspect, the present invention relates to the use of compounds of the formula (I) as active ingredients in the manufacture of medicaments/compositions for the prevention, control and treatment of conditions requiring modulation of inflammation. The compounds of formula (I) as defined above may also be useful (for the manufacture of a composition) for the management of pain, fever and injuries, especially sport injuries. Moreover, the compounds of formula (I) as defined above may also be useful (for the manufacture of a composition) for the maintenance and regeneration of articular cartilage.
摘要翻译：本发明涉及式（I）化合物的用途，其中凝血线是任选的键; 如果R2是羟基，R1是丁基或丁酰基，如果R2是氢，则是丁基; 或者R 1和R 2一起是被羟基，甲基或3-（α，β-二甲基丙烯酰氧基） - 戊酰基任选取代的1-亚丁基; X是选自X1，X2，X3，X4和X5的残基; 其中如果式（I）中的虚线不存在，X是X 2，X 3或X 5; 如果虚线表示上述式（I）中的键，X为X 1，X 4或X 5; R3是羟基或丁酰基; 和n为1或2，作为预防，控制和治疗需要调节哺乳动物炎症的病症的药剂。另一方面，本发明涉及式（I）化合物作为活性成分在制备用于预防，控制和治疗需要调节炎症的病症的药物/组合物中的用途。如上定义的式（I）化合物也可用于治疗疼痛，发烧和损伤，特别是运动损伤（用于制造组合物）。此外，如上定义的式（I）化合物也可用于维持和再生关节软骨（用于制备组合物）。

10. 发明申请

US20080319071A1 Novel Nutraceutical and Pharmaceutical Compositions and Use Thereof for the Treatment, Co-Treatment or Prevention of Inflammatory Disorders 失效
标题翻译：新型营养和药物组合物及其用途，用于治疗，共同治疗或预防炎性疾病
公开(公告)号：US20080319071A1
公开(公告)日：2008-12-25
申请号：US12279510
申请日：2007-02-13
申请人： Daniel Raederstorff , Joseph Schwager , Goede Schueler
发明人： Daniel Raederstorff , Joseph Schwager , Goede Schueler
IPC分类号： A61K31/20 , C07C65/28 , A61K31/085 , A61P19/02 , C07C43/23 , A61K31/192
CPC分类号： C07C43/23 , C07C65/28 , C07D311/58
摘要： The present invention relates to new methoxylated aromatic compounds. It also relates to novel compositions comprising methoxylated aromatic compounds as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.
摘要翻译：本发明涉及新的甲氧基化芳族化合物。它还涉及包含甲氧基化芳族化合物的新型组合物以及这些组合物作为药物，特别是作为治疗，共同治疗或预防炎症性疾病的药物的用途。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式